Georg Bartsch

15.7k total citations · 1 hit paper
340 papers, 10.7k citations indexed

About

Georg Bartsch is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Georg Bartsch has authored 340 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Pulmonary and Respiratory Medicine, 129 papers in Surgery and 68 papers in Molecular Biology. Recurrent topics in Georg Bartsch's work include Prostate Cancer Diagnosis and Treatment (105 papers), Prostate Cancer Treatment and Research (97 papers) and Urologic and reproductive health conditions (51 papers). Georg Bartsch is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (105 papers), Prostate Cancer Treatment and Research (97 papers) and Urologic and reproductive health conditions (51 papers). Georg Bartsch collaborates with scholars based in Austria, Germany and United States. Georg Bartsch's co-authors include Helmut Klocker, Wolfgang Horninger, Alfred Hobisch, Hannes Strasser, Ferdinand Frauscher, Anthony Atala, Reinhard Peschel, Paolo De Coppi, Shay Söker and Zoran Čulig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Georg Bartsch

327 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of amniotic stem cell lines with potential for therapy

2007 1.3k citations Georg Bartsch et al. profile →

Peers

Countries citing papers authored by Georg Bartsch

Since Specialization

Citations

This map shows the geographic impact of Georg Bartsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Bartsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Bartsch more than expected).

Fields of papers citing papers by Georg Bartsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Bartsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Bartsch. The network helps show where Georg Bartsch may publish in the future.

Co-authorship network of co-authors of Georg Bartsch

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Bartsch. A scholar is included among the top collaborators of Georg Bartsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Bartsch. Georg Bartsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis 2019 ·International Urology and Nephrology ·Christian Thomas, (unknown), Anita Thomas, Robert Dotzauer, Georg Bartsch, Axel Haferkamp, Igor Tsaur	18
2	Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survival 2018 ·International Urology and Nephrology ·Christian Thomas, Maximilian Peter Brandt, (unknown), Igor Tsaur, Sebastian Frees, Hendrik Borgmann, Wolfgang Jäger, Georg Bartsch, Meike Schneider, Robert Dotzauer, Andreas Neisius, Axel Haferkamp	11
3	What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital 2016 ·SHILAP Revista de lepidopterología ·(unknown), Stefan Vallo, (unknown), (unknown), Christine Bärtsch, (unknown), Igor Tsaur, Georg Bartsch, Axel Haferkamp	1
4	The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer 2012 ·Journal of Molecular Medicine ·Ruprecht Kuner, Maria Fälth, (unknown), Jan C. Brase, (unknown), (unknown), Stephan Gade, Georg Schäfer, Georg Bartsch, Eberhard Steiner, Helmut Klocker, Holger Sültmann	119
5	Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro 2012 ·Prostate Cancer and Prostatic Diseases ·(unknown), Stefan Vallo, (unknown), Jasmina Makarević, Eva Juengel, Georg Bartsch, Christoph Wiesner, Axel Haferkamp, Roman A. Blaheta	22
6	Models to Predict Positive Prostate Biopsies Using the Tyrol Screening Study 2011 ·Urology ·Prasanna Sooriakumaran, Majnu John, Paul J. Christos, Jasmin Bektić, Georg Bartsch, Robert Leung, Michael Herman, Douglas S. Scherr, Ashutosh Tewari	4
7	The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line 2011 ·Cancer Letters ·Igor Tsaur, Jasmina Makarević, Lukasz Hudak, Eva Juengel, M. Kurosch, Christoph Wiesner, Georg Bartsch, Sebastian Harder, Axel Haferkamp, Roman A. Blaheta	44
8	Prediction of Retroperitoneal Histology in Metastatic Nonseminomatous Testicular Cancer Patients after Chemotherapy Based on Clinical and Radiological Parameters 2010 ·Current Urology ·Hannes Steiner, (unknown), Brigitte Stöhr, (unknown), Reinhold Ramoner, Friedrich Aigner, Georg Bartsch, (unknown)	3
9	Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy 2009 ·Proceedings of the National Academy of Sciences ·C. Shad Thaxton, Robert Elghanian, Audrey Thomas, Savka I. Stoeva, Jae‐Seung Lee, Norm D. Smith, Anthony J. Schaeffer, Helmut Klocker, Wolfgang Horninger, Georg Bartsch, Chad A. Mirkin	298
10	Predicting the outcome of prostate biopsy: comparison of a novel logistic regression‐based model, the prostate cancer risk calculator, and prostate‐specific antigen level alone 2009 ·British Journal of Urology ·David J. Hernandez, Misop Han, Elizabeth B. Humphreys, Leslie A. Mangold, Samir S. Taneja, Stacy J. Childs, Georg Bartsch, Alan W. Partin	35
11	Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate‐specific antigen level: is there a difference? 2008 ·British Journal of Urology ·Alexandré Pelzer, Daniela Colleselli, Jasmin Bektić, Eberhard Steiner, Reinhold Ramoner, Michael Mitterberger, Christian Schwentner, Georg Schaefer, Stefano Ongarello, Georg Bartsch, Wolfgang Horninger	8
12	Gain of chromosome X in prostatic atrophy detected by CGH and FISH analyses 2007 ·The Prostate ·(unknown), Irmgard Verdorfer, Georg Schäfer, Hermann Rogatsch, Georg Bartsch, Gregor Mikuz	3
13	Adult Stem Cell Therapy of Female Stress Urinary Incontinence 2007 ·European Urology ·Michael Mitterberger, Germar‐Michael Pinggera, Rainer Marksteiner, Eva Margreiter, Martin Fussenegger, Ferdinand Frauscher, Hanno Ulmer, Steffen Hering, Georg Bartsch, Hannes Strasser	93
14	Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours 2006 ·The Journal of Steroid Biochemistry and Molecular Biology ·Petra Hååg, Ferdinand Frauscher, Johann Gradl, Alexander Seitz, Georg Schäfer, Jonathan R. Lindner, Alexander L. Klibanov, Georg Bartsch, Helmut Klocker, Iris E. Eder	83
15	Stimulation of growth of prostate cancer cells 22Rv1 through activation of the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase 2005 ·Cancer Research ·Hannes Steiner, Sonia Godoy‐Tundidor, Ilaria T. Cavarretta, Dietmar Fuchs, (unknown), Katrin Friedbichler, Georg Bartsch, Alfred Hobisch, Zoran Čulig	1
16	High-flow priapism: colour-Doppler ultrasound-guided supraselective embolization therapy 2004 ·World Journal of Urology ·Georg Bartsch, Rainer Kuefer, Oliver Engel, Bjoern G. Volkmer	13
17	Clinical and pathologic features of prostate cancer detected after repeat false‐negative biopsy in a screening population 2003 ·The Prostate ·Hannes Steiner, Patrizia Moser, Martina Hager, Andreas P. Berger, Helmut Klocker, Robert Spranger, Hermann Rogatsch, Georg Bartsch, Wolfgang Horninger	14
18	Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study 2002 ·Urology ·Hannes Steiner, Lorenz Höltl, (unknown), Andreas P. Berger, Georg Bartsch, Alfred Hobisch	48
19	Radical Prostatectomy: Technical Aspects and Management of Complications 2001 ·European Urology ·Georg Bartsch, Paul B. Perrin, L Boccon-Gibod, (unknown)	3
20	Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels 1997 ·The Prostate ·Andreas Reissigl, Helmut Klocker, (unknown), O. Ennemoser, Martin Falk, Georg Bartsch	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact